First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018

Blood Cancer J. 2021 Feb 4;11(2):22. doi: 10.1038/s41408-021-00415-5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Disease Management
  • Humans
  • Immunologic Factors / therapeutic use
  • Leukemia, Plasma Cell / diagnosis
  • Leukemia, Plasma Cell / epidemiology*
  • Leukemia, Plasma Cell / therapy*
  • Middle Aged
  • Netherlands / epidemiology
  • Proteasome Inhibitors / therapeutic use
  • Stem Cell Transplantation
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • Immunologic Factors
  • Proteasome Inhibitors